Literature DB >> 17113662

Lone and secondary nonvalvular atrial fibrillation: role of a genetic susceptibility.

Cinzia Fatini1, Elena Sticchi, Francesca Gensini, Anna Maria Gori, Rossella Marcucci, Meri Lenti, Antonio Michelucci, Maurizio Genuardi, Rosanna Abbate, Gian Franco Gensini.   

Abstract

BACKGROUND: An involvement of the renin angiotensin system in atrial fibrillation (AF) has been hypothesized, and ACE DD genotype has been suggested to influence the predisposition to AF. The aim of this study was to investigate the role of the ACE I/D polymorphism in relation to the different clinical forms of AF, lone and secondary nonvalvular atrial fibrillation (NVAF).
METHODS: 510 consecutive patients with documented NVAF (106 patients had lone, and 404 secondary NVAF), and 520 controls with a negative history of cardiovascular disease have been studied.
RESULTS: A significant difference in allele frequency between lone and secondary NVAF (p=0.002) has been found. The ACE D allele was associated with the predisposition to lone NVAF under a dominant, recessive and additive model, both at univariate and multivariate analysis, after adjustment for age and gender (multivariate analysis: dominant OR=2.87, p=0.02; recessive OR=2.01, p=0.003; additive OR=4.47, p<0.0001). ACE D allele was significantly associated with secondary NVAF at both univariate and multivariate analysis under a recessive and additive, but not dominant, model (multivariate analysis: recessive OR=1.89, p=0.001; additive OR=2.50, p<0.0001).
CONCLUSIONS: This study highlights the role of ACE gene in predisposing to both lone and secondary NVAF, further contributing to penetrate the genetic mechanisms responsible for this complex disease. The clinical relevance of our results may be related to the possible characterization of subjects predisposed to NVAF in the absence of traditional risk factors, and to the use of ACE-inhibitors therapy able to improve the arrhythmogenic substrate.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17113662     DOI: 10.1016/j.ijcard.2006.08.079

Source DB:  PubMed          Journal:  Int J Cardiol        ISSN: 0167-5273            Impact factor:   4.164


  12 in total

Review 1.  Genetics of atrial fibrillation.

Authors:  Steven A Lubitz; B Alexander Yi; Patrick T Ellinor
Journal:  Heart Fail Clin       Date:  2010-04       Impact factor: 3.179

2.  Lack of replication in polymorphisms reported to be associated with atrial fibrillation.

Authors:  Moritz F Sinner; Steven A Lubitz; Arne Pfeufer; Seiko Makino; Britt-Maria Beckmann; Kathryn L Lunetta; Gerhard Steinbeck; Siegfried Perz; Rosanna Rahman; Akshata Sonni; Steven M Greenberg; Karen L Furie; H-Erich Wichmann; Thomas Meitinger; Annette Peters; Emelia J Benjamin; Jonathan Rosand; Patrick T Ellinor; Stefan Kääb
Journal:  Heart Rhythm       Date:  2010-11-04       Impact factor: 6.343

Review 3.  Monogenic atrial fibrillation as pathophysiological paradigms.

Authors:  Saagar Mahida; Steven A Lubitz; Michiel Rienstra; David J Milan; Patrick T Ellinor
Journal:  Cardiovasc Res       Date:  2010-11-30       Impact factor: 10.787

4.  A genetic contribution to risk for postoperative junctional ectopic tachycardia in children undergoing surgery for congenital heart disease.

Authors:  Kristie Y Borgman; Andrew H Smith; Jill P Owen; Frank A Fish; Prince J Kannankeril
Journal:  Heart Rhythm       Date:  2011-07-06       Impact factor: 6.343

Review 5.  Recent advances in the molecular pathophysiology of atrial fibrillation.

Authors:  Reza Wakili; Niels Voigt; Stefan Kääb; Dobromir Dobrev; Stanley Nattel
Journal:  J Clin Invest       Date:  2011-08-01       Impact factor: 14.808

Review 6.  Genetics of atrial fibrillation: implications for future research directions and personalized medicine.

Authors:  Steven A Lubitz; Cevher Ozcan; Jared W Magnani; Stefan Kääb; Emelia J Benjamin; Patrick T Ellinor
Journal:  Circ Arrhythm Electrophysiol       Date:  2010-06

Review 7.  Genetics of atrial fibrillation.

Authors:  Steven A Lubitz; B Alexander Yi; Patrick T Ellinor
Journal:  Cardiol Clin       Date:  2009-02       Impact factor: 2.213

8.  Genetic variants related to height and risk of atrial fibrillation: the cardiovascular health study.

Authors:  Michael A Rosenberg; Robert C Kaplan; David S Siscovick; Bruce M Psaty; Susan R Heckbert; Christopher Newton-Cheh; Kenneth J Mukamal
Journal:  Am J Epidemiol       Date:  2014-06-18       Impact factor: 4.897

Review 9.  Non-antiarrhythmic medications for atrial fibrillation: from bench to clinical practice.

Authors:  Maya Guglin; Marcos Garcia; Michael J Yarnoz; Anne B Curtis
Journal:  J Interv Card Electrophysiol       Date:  2008-03-04       Impact factor: 1.900

10.  Genetic Discoveries in Atrial Fibrillation and Implications for Clinical Practice.

Authors:  Saagar Mahida
Journal:  Arrhythm Electrophysiol Rev       Date:  2014-08-30
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.